Case Reports

Drug-induced Linear IgA Bullous Dermatosis in a Patient With a Vancomycin-impregnated Cement Spacer

Author and Disclosure Information

Linear IgA bullous dermatosis (LABD) is an autoimmune blistering rash caused by IgA autoantibodies against the epidermal basement membrane zone. It commonly is drug induced, often in association with systemic vancomycin. We report a case of a previously healthy 77-year-old man who developed a diffuse macular rash and hemorrhagic bullae on the left leg 10 days after placement of a vancomycin-impregnated cement spacer (VICS) during a revision knee arthroplasty and initiation of postoperative treatment with intravenous (IV) vancomycin. The lesions initially were limited to the leg in which the hardware was placed, but the patient later developed painful palmoplantar and oropharyngeal blisters as well as edematous, erythematous plaques on the back and buttocks. A punch biopsy from a lesion on the left thigh revealed neutrophil-rich subepidermal bullae, and immunofluorescence revealed linear IgA and C3 deposition along the dermoepidermal junction, confirming a diagnosis of LABD. This report illustrates the importance of considering antibiotic-impregnated cement spacers, which frequently are used to manage prosthetic joint infections, as potential culprits in patients with cutaneous eruptions.

Practice Points

  • Linear IgA bullous dermatosis (LABD) is an autoimmune mucocutaneous disorder characterized by linear IgA deposits at the dermoepidermal junction.
  • A substantial number of cases of LABD are drug related, with vancomycin most commonly implicated.
  • While antibiotic-impregnated cement spacers deliver high concentrations of local medications, systemic reactions are still possible.
  • Dapsone is the first-line treatment for LABD.


 

References

Case Report

A 77-year-old man was admitted to the general medicine service at our institution for treatment of a diffuse macular eruption and hemorrhagic bullae 12 days after undergoing left-knee revision arthroplasty during which a cement spacer impregnated with vancomycin and tobramycin was placed. At the time of the surgery, the patient also received intravenous (IV) vancomycin and oral ciprofloxacin, which were continued postoperatively until his hospital presentation. The patient was recovering well until postoperative day 7, when he developed painful swelling and erythema surrounding the surgical wound on the left knee. Concerned that his symptoms indicated a flare of gout, he restarted a former allopurinol prescription from an outside physician after 2 years of nonuse. The skin changes progressed distally on the left leg over the next 48 hours. By postoperative day 10, he had developed serosanguinous blisters on the left knee (Figure 1A) and oral mucosa (Figure 1B), as well as erythematous nodules on the bilateral palms. He presented to our institution for emergent care on postoperative day 12 following progression of the eruption to the inguinal region (Figure 2A), buttocks (Figure 2B), and abdominal region.

Figure 1. Scattered serosanguinous blisters with erythematous bases localized on the left knee (postoperative day 14)(A) and blistering of the anterior soft palate with epithelial sloughing visible on the right hard palate and buccal mucosa (postoperative day 12)(B) that developed after placement of a vancomycin-impregnated cement spacer during a revision knee arthroplasty.

Figure 2. Annular erythematous plaques with centralized bullous formation in the inguinal region (postoperative day 14)(A) and buttocks (postoperative day 18)(B) following placement of a vancomycin-impregnated cement spacer during a revision knee arthroplasty.

Due to concerns about a potential drug reaction, the IV vancomycin, oral ciprofloxacin, and oral allopurinol were discontinued on hospital admission. A dermatology consultation (D.A.D., J.A.Z., E.T.) was obtained, and a punch biopsy from a lesion on the left thigh revealed a neutrophil-rich subepidermal bulla with scattered eosinophils (Figure 3A). Direct immunofluorescence demonstrated linear IgA (Figure 3B) and C3 deposition along the dermoepidermal junction, which confirmed a diagnosis of drug-induced linear IgA bullous dermatosis (LABD). Vancomycin was suspected as the causative agent.1 An initial vancomycin trough level drawn 48 hours after discontinuation (postoperative day 13) was still therapeutic at 14 µg/mL (reference range, 10–20 µg/mL in adults). This was substantially higher than the predicted value of 3 µg/mL based on renal excretion. Similarly, 5 additional serum levels obtained during the patient’s hospital course were greater than those predicted, and follow-up trough levels remained detectable at 1 µg/mL 2 weeks after discontinuation.

Figure 3. A neutrophil-rich subepidermal bulla with scattered eosinophils was noted on staining with hematoxylin and eosin (A)(original magnification ×20), and direct immunofluorescence demonstrated linear IgA deposition along the dermoepidermal junction (B)(original magnification ×20).

Oral prednisone 60 mg once daily and oral dapsone 25 mg once daily were initiated on hospital days 4 and 6 (postoperative days 15 and 17), respectively. A 6-week course of oral ciprofloxacin 750 mg twice daily and daptomycin 8 mg/kg once daily was initiated for bacterial coverage on hospital day 5 (postoperative day 16). Topical triamcinolone and an anesthetic mouthwash also were used to treat the mucosal involvement. The lesions stabilized on the third day of steroid therapy, and the patient was discharged 7 days after hospital admission (postoperative day 18). Dapsone was rapidly increased to 100 mg once daily over the next week for Pneumocystis jirovecii pneumonia prophylaxis. An increase in prednisone to 80 mg once daily was required 3 days after the patient was discharged due to worsening oral lesions. Five days after discharge, the patient was readmitted to the hospital for 3 days due to acute kidney injury (AKI) in which his baseline creatinine level tripled. The cause of renal impairment was unknown, resulting in empiric discontinuation of dapsone on postoperative day 27. Prophylaxis for P jirovecii pneumonia was replaced with once-monthly inhaled pentamidine. Prednisone was tapered 20 days after the original presentation (postoperative day 32) following gradual improvement of both the skin and oral lesions. At dermatology follow-up 2 weeks later, doxycycline 100 mg twice daily was added for residual inflammation of the left leg. A deep vein thrombosis was discovered in the left leg 10 days later, and 3 months of anticoagulation therapy was initiated with discontinuation of the doxycycline. The patient continued to have renal insufficiency several weeks after dapsone discontinuation and developed prominent peripheral motor neuropathy with bilateral thenar atrophy. He did not experience any skin eruptions or relapses in the weeks following prednisone cessation and underwent successful removal of the cement spacer with full left-knee reconstruction 4 months after his initial presentation to our institution. At 9-month dermatology follow-up, the LABD remained in remission.

Pages

Recommended Reading

Bar soaps may be better than body washes for contact dermatitis patients
MDedge Dermatology
VIDEO: When to consider systemic exposure in patients with contact dermatitis
MDedge Dermatology
Granulomatous Pigmented Purpuric Dermatosis
MDedge Dermatology
Working up patients with allergic contact dermatitis
MDedge Dermatology
Metals may surprise as sources of contact dermatitis
MDedge Dermatology
Consider calcipotriol contact allergy when psoriasis doesn’t improve
MDedge Dermatology
Over-the-counter Topical Musculoskeletal Pain Relievers Used With a Heat Source: A Dangerous Combination
MDedge Dermatology
VIDEO: The skinny on patch testing
MDedge Dermatology
VIDEO: Parabens named ‘nonallergen’ of the year
MDedge Dermatology
VIDEO: Select atopic dermatitis patients need patch testing
MDedge Dermatology